Cargando…

Rifampicin‐induced acute tubulointerstitial nephritis during pulmonary tuberculosis treatment: A case report

Drug‐induced tubulointerstitial nephritis is an uncommon complication in patients on anti‐tuberculosis therapy that can lead to permanent kidney damage. Rifampicin is the most offending drug. We report a case of a 41‐years old man being treated for pulmonary tuberculosis and presenting with tubuloin...

Descripción completa

Detalles Bibliográficos
Autores principales: Moussa, Chirine, Esbaa, Samia, Rouis, Houda, Sellami, Nada, Hajji, Meriam, Houcine, Yoldez, Khattab, Amel, Khouaja, Ibtihel, Zendah, Ines, Maâlej, Sonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352592/
https://www.ncbi.nlm.nih.gov/pubmed/37469571
http://dx.doi.org/10.1002/rcr2.1190
_version_ 1785074540331663360
author Moussa, Chirine
Esbaa, Samia
Rouis, Houda
Sellami, Nada
Hajji, Meriam
Houcine, Yoldez
Khattab, Amel
Khouaja, Ibtihel
Zendah, Ines
Maâlej, Sonia
author_facet Moussa, Chirine
Esbaa, Samia
Rouis, Houda
Sellami, Nada
Hajji, Meriam
Houcine, Yoldez
Khattab, Amel
Khouaja, Ibtihel
Zendah, Ines
Maâlej, Sonia
author_sort Moussa, Chirine
collection PubMed
description Drug‐induced tubulointerstitial nephritis is an uncommon complication in patients on anti‐tuberculosis therapy that can lead to permanent kidney damage. Rifampicin is the most offending drug. We report a case of a 41‐years old man being treated for pulmonary tuberculosis and presenting with tubulointerstitial nephritis associated with rifampicin. We focus on diagnosis features and therapeutic challenges.
format Online
Article
Text
id pubmed-10352592
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-103525922023-07-19 Rifampicin‐induced acute tubulointerstitial nephritis during pulmonary tuberculosis treatment: A case report Moussa, Chirine Esbaa, Samia Rouis, Houda Sellami, Nada Hajji, Meriam Houcine, Yoldez Khattab, Amel Khouaja, Ibtihel Zendah, Ines Maâlej, Sonia Respirol Case Rep Case Reports Drug‐induced tubulointerstitial nephritis is an uncommon complication in patients on anti‐tuberculosis therapy that can lead to permanent kidney damage. Rifampicin is the most offending drug. We report a case of a 41‐years old man being treated for pulmonary tuberculosis and presenting with tubulointerstitial nephritis associated with rifampicin. We focus on diagnosis features and therapeutic challenges. John Wiley & Sons, Ltd 2023-07-17 /pmc/articles/PMC10352592/ /pubmed/37469571 http://dx.doi.org/10.1002/rcr2.1190 Text en © 2023 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Moussa, Chirine
Esbaa, Samia
Rouis, Houda
Sellami, Nada
Hajji, Meriam
Houcine, Yoldez
Khattab, Amel
Khouaja, Ibtihel
Zendah, Ines
Maâlej, Sonia
Rifampicin‐induced acute tubulointerstitial nephritis during pulmonary tuberculosis treatment: A case report
title Rifampicin‐induced acute tubulointerstitial nephritis during pulmonary tuberculosis treatment: A case report
title_full Rifampicin‐induced acute tubulointerstitial nephritis during pulmonary tuberculosis treatment: A case report
title_fullStr Rifampicin‐induced acute tubulointerstitial nephritis during pulmonary tuberculosis treatment: A case report
title_full_unstemmed Rifampicin‐induced acute tubulointerstitial nephritis during pulmonary tuberculosis treatment: A case report
title_short Rifampicin‐induced acute tubulointerstitial nephritis during pulmonary tuberculosis treatment: A case report
title_sort rifampicin‐induced acute tubulointerstitial nephritis during pulmonary tuberculosis treatment: a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352592/
https://www.ncbi.nlm.nih.gov/pubmed/37469571
http://dx.doi.org/10.1002/rcr2.1190
work_keys_str_mv AT moussachirine rifampicininducedacutetubulointerstitialnephritisduringpulmonarytuberculosistreatmentacasereport
AT esbaasamia rifampicininducedacutetubulointerstitialnephritisduringpulmonarytuberculosistreatmentacasereport
AT rouishouda rifampicininducedacutetubulointerstitialnephritisduringpulmonarytuberculosistreatmentacasereport
AT sellaminada rifampicininducedacutetubulointerstitialnephritisduringpulmonarytuberculosistreatmentacasereport
AT hajjimeriam rifampicininducedacutetubulointerstitialnephritisduringpulmonarytuberculosistreatmentacasereport
AT houcineyoldez rifampicininducedacutetubulointerstitialnephritisduringpulmonarytuberculosistreatmentacasereport
AT khattabamel rifampicininducedacutetubulointerstitialnephritisduringpulmonarytuberculosistreatmentacasereport
AT khouajaibtihel rifampicininducedacutetubulointerstitialnephritisduringpulmonarytuberculosistreatmentacasereport
AT zendahines rifampicininducedacutetubulointerstitialnephritisduringpulmonarytuberculosistreatmentacasereport
AT maalejsonia rifampicininducedacutetubulointerstitialnephritisduringpulmonarytuberculosistreatmentacasereport